Delaware
|
33-0591385
|
(State
or other jurisdiction of
|
(I.R.S.
Empl. Ident. No.)
|
incorporation
or organization)
|
|
16770
West Bernardo Drive, San Diego, California
|
92127
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Large
Accelerated Filer ¨
|
Accelerated
filer ¨
|
Non-accelerated
filer ¨ (Do not check if a smaller
reporting company)
|
Smaller
reporting company x
|
Page
|
|||
PART
I. FINANCIAL INFORMATION
|
|||
Item
1.
|
Financial
Statements (unaudited):
|
||
Consolidated
Balance Sheets as of June 30, 2009
|
|||
and
March 31, 2009
|
3
|
||
Consolidated
Statements of Operations for the three
|
|||
months
ended June 30, 2009 and 2008
|
4
|
||
Consolidated
Statements of Cash Flows for the three
|
|||
months
ended June 30, 2009 and 2008
|
5
|
||
Notes
to Interim Consolidated Financial Statements
|
6
|
||
Item
2.
|
Management's
Discussion and Analysis of Financial
|
||
Condition
and Results of Operations
|
14
|
||
Item
4.
|
Controls
and Procedures
|
18
|
|
PART
II. OTHER INFORMATION
|
|||
Item
1.
|
Legal
Proceedings
|
19
|
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
20
|
|
Item
3.
|
Defaults
Upon Senior Securities
|
20
|
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
20
|
|
Item
5.
|
Other
Information
|
20
|
|
Item
6.
|
Exhibits
|
20
|
|
SIGNATURES
|
21
|
June 30,
|
||||||||
2009
|
March 31,
|
|||||||
(Unaudited)
|
2009
|
|||||||
$
|
$
|
|||||||
ASSETS
|
||||||||
Current
|
||||||||
Cash
and cash equivalents
|
3,073,779 | 3,813,990 | ||||||
Accounts
receivable
|
218,539 | 93,771 | ||||||
Inventory
|
519,327 | 517,163 | ||||||
Deposits
and prepaid expenses
|
31,196 | 26,108 | ||||||
Total
current assets
|
3,842,841 | 4,451,032 | ||||||
Property,
equipment and intangibles, net of accumulated depreciation
|
||||||||
and
amortization of $170,506 and $165,449, respectively
|
21,581 | 26,638 | ||||||
Total
assets
|
3,864,422 | 4,477,670 | ||||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
Current
|
||||||||
Accounts
payable, trade
|
356,820 | 202,900 | ||||||
Accrued
and other liabilities
|
385,958 | 589,814 | ||||||
Current
maturity of convertible term note, net of $2,489 and $6,141 of debt
discount
|
241,112 | 381,093 | ||||||
Total
current liabilities
|
983,890 | 1,173,807 | ||||||
Deferred
revenue - long term
|
8,000 | 24,000 | ||||||
Total
long-term liabilities
|
8,000 | 24,000 | ||||||
Total
liabilities
|
991,890 | 1,197,807 | ||||||
Commitments
and Contingencies
|
||||||||
Stockholders'
equity
|
||||||||
Preferred
stock, $0.001 par value; 5,000,000 shares authorized
|
||||||||
Series
AA Convertible Preferred stock, $0.001 par value, 100,000
|
||||||||
shares designated: 75,000 and 75,000 issued and outstanding,
respectively
|
||||||||
Liquidation
preference of $787,808 and $778,459, respectively
|
653,587 | 610,774 | ||||||
Common
stock, $0.001 par value, authorized 350,000,000,
|
||||||||
283,320,838
and 282,124,564 shares issued and outstanding,
respectively
|
283,321 | 282,125 | ||||||
Additional
paid-in capital
|
81,652,302 | 81,534,566 | ||||||
Accumulated
deficit
|
(79,716,678 | ) | (79,147,602 | ) | ||||
Total
stockholders' equity
|
2,872,532 | 3,279,863 | ||||||
Total
liabilities and stockholders' equity
|
3,864,422 | 4,477,670 |
For the three months ended
|
||||||||
June 30
|
||||||||
2009
|
2008
|
|||||||
Revenues:
|
$
|
$
|
||||||
Products
|
14,075 | 234,298 | ||||||
Services
|
208,955 | 143,429 | ||||||
Patent
license
|
- | - | ||||||
223,030 | 377,727 | |||||||
Cost
of revenues:
|
||||||||
Products
|
49,004 | 193,484 | ||||||
Services
|
71,974 | 70,186 | ||||||
Patent
license
|
- | - | ||||||
120,978 | 263,670 | |||||||
Gross
profit
|
102,052 | 114,057 | ||||||
Operating
expenses:
|
||||||||
Selling
and administrative
|
576,672 | 538,895 | ||||||
Research
and related expenditures
|
79,581 | 146,651 | ||||||
Total
operating expenses
|
656,253 | 685,546 | ||||||
Operating
loss
|
(554,201 | ) | (571,489 | ) | ||||
Other
income (expense):
|
||||||||
Interest
and other income
|
- | 5,055 | ||||||
Interest
expense
|
(10,047 | ) | (48,594 | ) | ||||
Warrant
and other finance expenses
|
(4,828 | ) | (54,179 | ) | ||||
Other
expense
|
(14,875 | ) | (97,718 | ) | ||||
Loss
before provision for income taxes
|
(569,076 | ) | (669,207 | ) | ||||
Provision
for income taxes
|
- | - | ||||||
Loss
for the period
|
(569,076 | ) | (669,207 | ) | ||||
Accrued
and deemed dividends on preferred stock
|
(42,813 | ) | (1,411 | ) | ||||
Loss
attributable to common stockholders
|
(611,889 | ) | (670,618 | ) | ||||
Loss
per common share - basic and diluted
|
$ | (0.00 | ) | $ | (0.00 | ) | ||
Weighted
average common shares outstanding
|
282,507,374 | 274,497,647 |
For
the three months ended
|
||||||||
June
30
|
||||||||
2009
|
2008
|
|||||||
|
$
|
$
|
||||||
OPERATING
ACTIVITIES
|
||||||||
Loss
for the period
|
(569,076 | ) | (669,207 | ) | ||||
Adjustments
to reconcile loss to net cash used in operating
activities:
|
||||||||
Depreciation
and amortization
|
5,057 | 4,280 | ||||||
Accretion
related to promissory notes
|
3,652 | 13,016 | ||||||
Warrant
modification and warrant derivative revaluation
|
- | 50,759 | ||||||
Interest
paid with common stock
|
6,367 | 14,155 | ||||||
Warranty
provision
|
11,872 | 10,080 | ||||||
Stock-based
compensation
|
11,745 | 14,721 | ||||||
Changes
in assets and liabilities:
|
||||||||
Accounts
receivable, trade
|
(124,768 | ) | 70,675 | |||||
Inventories
|
(2,164 | ) | (56,663 | ) | ||||
Prepaid
expenses and other
|
(5,088 | ) | (1,356 | ) | ||||
Accounts
payable, trade
|
153,920 | 284,327 | ||||||
Accrued
and other liabilities
|
(193,080 | ) | (48,721 | ) | ||||
Accrued
employee benefits
|
(21,168 | ) | 5,128 | |||||
Warranty
reserve
|
(9,889 | ) | (15,996 | ) | ||||
Deferred
revenue
|
(7,591 | ) | (9,500 | ) | ||||
Cash
used in operating activities
|
(740,211 | ) | (334,302 | ) | ||||
FINANCING
ACTIVITIES
|
||||||||
Proceeds
from sale of common stock
|
- | 340,000 | ||||||
Proceeds
from sale of preferred stock
|
- | 700,000 | ||||||
Payments
on secured promissory note
|
- | (50,000 | ) | |||||
Proceeds
from unsecured promissory note
|
- | 40,000 | ||||||
Cash
provided by financing activities
|
- | 1,030,000 | ||||||
Net
increase (decrease) in cash and cash equivalents
|
(740,211 | ) | 695,698 | |||||
Cash
and cash equivalents, beginning of period
|
3,813,990 | 122,116 | ||||||
Cash
and cash equivalents, end of period
|
3,073,779 | 817,814 | ||||||
Supplemental
disclosures of cash flow information:
|
||||||||
Cash
paid for interest
|
28 | 20,250 | ||||||
Cash
paid for taxes
|
160,000 | - | ||||||
Supplemental
schedule of noncash investing and financing activities:
|
||||||||
Accounts
payable exchanged for preferred stock
|
- | 50,000 | ||||||
Accrued
and deemed dividends on preferred stock
|
42,813 | 1,411 | ||||||
Term
note payments paid in common stock
|
150,000 | 90,000 | ||||||
Financing
fees paid in common stock
|
- | 4,800 |
June 30,
|
March 31,
|
|||||||
2009
|
2009
|
|||||||
$
|
$
|
|||||||
Raw
materials
|
45,504 | 35,330 | ||||||
Work
in process
|
313,800 | 316,734 | ||||||
Finished
goods
|
160,023 | 165,099 | ||||||
519,327 | 517,163 |
Three
Months Ended
|
||||||||
June
30,
|
||||||||
2009
|
2008
|
|||||||
Volatility
|
- | 70.5 | % | |||||
Risk-free
interest rate
|
- | 2.5 | % | |||||
Forfeiture
rate
|
- | 0.0 | % | |||||
Dividend
yield
|
- | 0.0 | % | |||||
Expected
life in years
|
- | 3.5 | ||||||
Weighted-average
fair value of options granted
|
- | $ | 0.06 |
Three
Months Ended June 30,
|
2009
|
2008
|
||||||
|
$
|
$
|
||||||
Beginning
balance
|
14,155 | 109,138 | ||||||
Warranty
provision
|
11,872 | 10,080 | ||||||
Warranty deductions
|
(9,889 | ) | (15,996 | ) | ||||
Ending balance
|
16,138 | 103,222 |
Preferred stock
|
Common stock
|
Additional
|
Accumulated
|
|||||||||||||||||||||
Amount
|
Shares
|
Amount
|
paid-in capital
|
deficit
|
Total
|
|||||||||||||||||||
Balance,
March 31, 2009
|
610,774 | 282,124,564 | 282,125 | 81,534,566 | (79,147,602 | ) | 3,279,863 | |||||||||||||||||
Dividends
on Series AA preferred stock
|
9,349 | - | - | (9,349 | ) | - | - | |||||||||||||||||
Accretion
of discount on Series AA preferred stock
|
33,464 | - | - | (33,464 | ) | - | - | |||||||||||||||||
Shares
issued for term debt payments
|
- | 1,196,274 | 1,196 | 148,804 | - | 150,000 | ||||||||||||||||||
Stock-based
compensation
|
- | - | - | 11,745 | - | 11,745 | ||||||||||||||||||
Loss
and comprehensive loss
|
- | - | - | - | (569,076 | ) | (569,076 | ) | ||||||||||||||||
Balance,
June 30, 2009
|
653,587 | 283,320,838 | 283,321 | 81,652,302 | (79,716,678 | ) | 2,872,532 |
Weighted average
|
Aggregate
|
|||||||||||
Shares
|
exercise price
|
Intrinsic Value
|
||||||||||
|
#
|
$
|
$
|
|||||||||
Outstanding
March 31, 2009
|
8,050,500 | 0.16 | ||||||||||
Granted
|
- | |||||||||||
Exercised
|
- | |||||||||||
Canceled/expired
|
- | |||||||||||
Outstanding
June 30, 2009
|
8,050,500 | 0.16 | 4,000 | |||||||||
Exercisable
at June 30, 2009
|
6,829,665 | 0.16 | 1,333 |
(1)
|
Options
outstanding are exercisable at prices ranging from $0.09 to $0.28 and
expire over the period from 2009 to
2013.
|
(2)
|
Aggregate
intrinsic value is based on the closing price of our common stock on June
30, 2009 of $0.115 and excludes the impact of options that were not
in-the-money.
|
Number of
|
Exercise Price
|
|||||
Description
|
Common Shares
|
Per Share $
|
Expiration Date
|
|||
Warrants
|
2,331,572
|
0.15
|
August
31, 2009
|
|||
Warrants
|
7,500,000
|
0.10
|
June
30, 2011
|
|||
9,831,572
|
Fair Value Measurement as of June 30, 2009
|
||||||||||||||||
Total
|
Level 1
|
Level 2
|
Level 3
|
|||||||||||||
Description
|
$ | $ | $ | $ | ||||||||||||
Cash
and cash equivalents (1)
|
3,073,779 | 3,073,779 | - | - |
|
(1)
|
Included
in cash and cash equivalents on the accompanying consolidated balance
sheet.
|
Three
months ended June 30,
|
2009
|
2008
|
||||||
$ | $ | |||||||
REVENUES:
|
||||||||
Products
and services
|
223,030 | 377,727 | ||||||
Patent
licensing
|
- | - | ||||||
Total
revenue
|
223,030 | 377,727 | ||||||
GROSS
PROFIT:
|
||||||||
Products
and services
|
102,052 | 114,057 | ||||||
Patent
licensing
|
- | - | ||||||
Total
gross profit
|
102,052 | 114,057 | ||||||
RECONCILIATION:
|
||||||||
Total
segment gross profit
|
102,052 | 114,057 | ||||||
Operating
expenses
|
(656,253 | ) | (685,546 | ) | ||||
Other
income (expense)
|
(14,875 | ) | (97,718 | ) | ||||
Income
(loss) before provision for income taxes
|
(569,076 | ) | (669,207 | ) |
Three Months Ended June 30,
|
||||||||||||||||||||||||
2009
|
2008
|
|||||||||||||||||||||||
% of
|
|
% of
|
Change
|
|||||||||||||||||||||
Dollars
|
Revenue
|
Dollars
|
Revenue
|
Dollars
|
%
|
|||||||||||||||||||
Revenues:
|
||||||||||||||||||||||||
Products
|
14,075 | 6 | % | 234,298 | 62 | % | (220,223 | ) | (94 | )% | ||||||||||||||
Services
|
208,955 | 94 | % | 143,429 | 38 | % | 65,526 | 46 | % | |||||||||||||||
Patent
license
|
- | 0 | % | - | 0 | % | - | |||||||||||||||||
223,030 | 100 | % | 377,727 | 100 | % | (154,697 | ) | (41 | )% | |||||||||||||||
Gross
Profit:
|
||||||||||||||||||||||||
Product
gross profit
|
(34,929 | ) | (16 | )% | 40,814 | 11 | % | (75,743 | ) | (186 | )% | |||||||||||||
Service
gross profit
|
136,981 | 61 | % | 73,243 | 19 | % | 63,738 | 87 | % | |||||||||||||||
Patent
license
|
- | 0 | % | - | 0 | % | - | |||||||||||||||||
102,052 | 46 | % | 114,057 | 30 | % | (12,005 | ) | (11 | )% | |||||||||||||||
Operating
Expenses:
|
||||||||||||||||||||||||
Selling
and administrative
|
576,672 | 259 | % | 538,895 | 143 | % | 37,777 | 7 | % | |||||||||||||||
Research
and related
|
79,581 | 36 | % | 146,651 | 39 | % | (67,070 | ) | (46 | )% | ||||||||||||||
656,253 | 294 | % | 685,546 | 181 | % | (29,293 | ) | (4 | )% | |||||||||||||||
Other
expenses
|
(14,875 | ) | (7 | )% | (97,718 | ) | (26 | )% | 82,843 | (85 | )% | |||||||||||||
Loss
before provision for income taxes
|
(569,076 | ) | (255 | )% | (669,207 | ) | (177 | )% | 100,131 | (15 | )% |
(a)
|
The following
common shares were issued during the fiscal quarter and not previously
reported in a Quarterly Report on Form 10-Q or Current Report on Form
8-K:
|
|
·
|
On
April 30, 2009 the Company issued 377,358 shares of common stock to Davric
Corporation in consideration of a $50,000 monthly payment on its 7.5% term
note. The shares were sold upon the exemption provided by Section 4(2)
under the Securities Act of 1933, no commissions were paid and a
restrictive legend was placed on the shares
issued.
|
|
·
|
On
May 29, 2009 the Company issued 369,276 shares of common stock to Davric
Corporation in consideration of a $50,000 monthly payment on its 7.5% term
note. The shares were sold upon the exemption provided by Section 4(2)
under the Securities Act of 1933, no commissions were paid and a
restrictive legend was placed on the shares
issued.
|
|
·
|
On
June 30, 2009 the Company issued 449,640 shares of common stock to Davric
Corporation in consideration of a $50,000 monthly payment on its 7.5% term
note. The shares were sold upon the exemption provided by Section 4(2)
under the Securities Act of 1933, no commissions were paid and a
restrictive legend was placed on the shares
issued.
|
|
(b)
|
NONE
|
|
(c)
|
NONE
|
e.DIGITAL
CORPORATION
|
|||
Date: August
13, 2009
|
By:
|
/s/ ROBERT PUTNAM
|
|
Robert
Putnam, Interim Chief Accounting Officer
|
|||
(Principal
Accounting and Financial Officer and duly authorized to sign on behalf of
the
Registrant)
|